CDK6 and cancer: When correlating sensitivity to CSN5 inhibition with the genetic background of the tested cancer cell lines47, we found that cell lines with CDK6 amplification (JHH-4, NOMO-1, OCI-M1 and SU-DHL-6) were highly sensitive and reached Amax values of ≤−95%.